Researchers from Cincinnati Children’s Hospital Medical Center have received $2.3 million in federal grants to continue research into treatments for leukemia and bone marrow failure.
The two grants come from the National Institutes of Health and are intended to help fund five years of research, according to a statement from Cincinnati Children’s.
The first grant totals $1.04 million and involves research into blocking a protein that initiates disease in bone marrow and leukemia stem cells. Researchers have been studying the protein’s effect in acute myeloid leukemia, a complex blood cancer that starts inside bone marrow and develops quickly. That research is being led by Yi Zheng and James Mulloy.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The second grant amounts to $1.25 million. It focuses on how certain proteins affect hematopoiesis, which refers to the development of blood cells in bone marrow. That research is being led by Qishen Pang.
Last year, Cincinnati Children’s was named one of the 10 best children’s hospitals in the country by U.S. News and World Report. The hospital ranked No. 1 in digestive disorders.
U.S. News creates its much-debated rankings based on reputation, outcomes and “care-related measures,” including technology and nursing care, and also based on opinions of where physicians would send their sickest patients.
